No Plasmatic Proteomic Signature at Clinical Disease Onset Associated With 11 Year Clinical, Cognitive and MRI Outcomes in Relapsing-Remitting Multiple Sclerosis Patients. [electronic resource]
- Frontiers in molecular neuroscience 2018
- 371 p. digital